CaridianBCT has received CE Mark approval for the expanded use of its Mirasol pathogen reduction technology system, which improves the safety of transfused blood products by reducing the levels of infectious pathogens. The approval will allow for the storage of platelets in 100% plasma or in an approved platelet additive solution.

Related Summaries